Emsam

Product manufactured by Mylan Specialty L.p.

Application Nr Approved Date Route Status External Links
NDA021336 2006-02-27 Transdermal RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Emsam (selegiline Transdermal System) Is A Monoamine Oxidase Inhibitor (maoi) Indicated For The Treatment Of Adults With Major Depressive Disorder (mdd) [see Clinical Studies (14) ]. EmsamĀ® (selegiline Transdermal System) Is A Monoamine Oxidase Inhibitor (maoi) Indicated For The Treatment Of Major Depressive Disorder (mdd) (1).

All Formulated Excipients (2 Total)

Name Structure Kind Function Status
1. Polyester POLYESTER Unresolved
2. Polyurethane POLYURETHANE Unresolved

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Selegiline SELEGILINE ZINC19632633

Comments